Leading the way to safer medication
 Crosscheck  Recommender


Therapeutic Indications

Brivudine is indicated for:

at least one of
Zoster [herpes zoster]

Human herpesvirus 3
and additionally at least one of
Immunodeficiency with predominantly antibody defects

Severe combined immunodeficiency [SCID] with reticular dysgenesis

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

Other combined immunodeficiencies

Combined immunodeficiency, unspecified

Immunodeficiency associated with other major defects

Common variable immunodeficiency

Other immunodeficiencies

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral


Active ingredient Brivudine is contraindicated in the following cases:

No gender/age discrimination

at least one of


Antineoplastic and immunomodulating agents